NCT04566393 2026-01-28Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesxCuresAvailable
NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT02209441 2014-08-06Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric CancerChineseAMSAvailable